NYSE:CB
NYSE:CBInsurance

Chubb (CB): Reassessing Valuation After SuretyBind Tech Collaboration With Major Industry Peers

Chubb (CB) has partnered with The Hartford, Liberty Mutual and Travelers to launch SuretyBind, LLC, a shared tech platform designed to modernize how surety bonds are transmitted, executed and verified across the industry. See our latest analysis for Chubb. Investors seem to be rewarding Chubb for initiatives like SuretyBind, with the share price now at $301.22 and a solid 30 day share price return of 4.75 percent helping extend a strong multi year total shareholder return trend. If this kind...
NYSE:XOM
NYSE:XOMOil and Gas

Is Exxon Mobil Still Attractive at $118 After Years of Strong Gains?

Wondering if Exxon Mobil at around $118 a share is still a buy or if the easy money has already been made? This article will walk through what the current price really implies about its value. The stock has been mostly flat over the last month at 0.0%, but it is still up 10.2% year to date and 231.1% over five years. That tells you the longer term trend has been much kinder than the recent trading range. Recent moves have been shaped by shifting expectations around global energy demand and...
TSE:6963
TSE:6963Semiconductor

Is ROHM’s New SiC MOSFET and Optical Sensor Lineup Altering The Investment Case For ROHM (TSE:6963)?

ROHM Semiconductor recently began mass production of its SCT40xxDLL SiC MOSFET series in compact TOLL packages and its RPR-0730 high-precision analog optical sensor, targeting high-power-density systems like AI servers, ESS, printers, and conveyor equipment. By combining higher-voltage, thermally efficient SiC devices with ultra-compact, fast optical sensing, ROHM is sharpening its focus on miniaturized, high-performance industrial and computing applications. We’ll now examine how the new...
ASX:MSB
ASX:MSBBiotechs

Mesoblast (ASX:MSB) Valuation Check as Investors Eye Piper Sandler Healthcare Conference Update

Mesoblast (ASX:MSB) steps into the spotlight this week as CEO Silviu Itescu presents at the Piper Sandler 37th Annual Healthcare Conference, and traders are watching for fresh color on strategy and late stage trials. See our latest analysis for Mesoblast. That anticipation has arrived on the back of a strong near term rebound, with a 1 month share price return of 27.03 percent and a 1 year total shareholder return of 65.88 percent, even though the year to date share price return remains...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Wingstop (WING): Assessing Valuation After a 15% Year-To-Date Share Price Pullback

Wingstop (WING) has quietly slipped this year, with the stock down about 15% year to date even as revenue and net income keep growing. That disconnect is what makes the setup interesting. See our latest analysis for Wingstop. After a huge multiyear run, Wingstop’s year to date share price return of negative 15.26 percent, including a 90 day share price return of negative 9.91 percent, suggests momentum has cooled even as the three year total shareholder return sits comfortably positive. If...
NasdaqGS:PTON
NasdaqGS:PTONLeisure

How Peloton’s 2025 Holiday Discount Blitz Will Impact Peloton Interactive (PTON) Investors

Peloton Interactive recently launched its 2025 holiday sales event, rolling out discounts across its Bikes, Treads, and Rows to stimulate demand during the crucial shopping season. This push comes on the heels of a broader company overhaul under new CEO Peter Stern, including AI-enhanced products and a sharper focus on profitability and free cash flow. Next, we’ll explore how Peloton’s holiday discount push, aimed at lifting hardware volumes, could reshape the company’s broader investment...
NYSE:ALL
NYSE:ALLInsurance

The Bull Case For Allstate (ALL) Could Change Following Mixed Revenue And Earnings Beat – Learn Why

In the past quarter, Allstate reported earnings per share and net premiums earned that exceeded analyst expectations, even as overall revenue slipped slightly and fell short of forecasts. This performance highlights how hard market conditions and easing inflation are supporting Allstate’s property and casualty operations, despite headline revenue softness. We’ll now examine how Allstate’s earnings beat and stronger net premiums earned may influence the company’s broader investment...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Microsoft (MSFT): Taking Stock of Valuation After New $17.5B India and CAD 7.5B Canada AI Investments

Microsoft (MSFT) just doubled down on its AI future, committing $17.5 billion to new AI infrastructure in India and more than CAD 7.5 billion in Canada, a capital intensive bet that directly shapes the stock’s longer term growth story. See our latest analysis for Microsoft. Despite a modest pullback recently, with the 30 day share price return at minus 2.76 percent and the 90 day share price return at minus 1.79 percent, Microsoft’s longer term picture remains strong. This includes a 3 year...
NYSE:MCO
NYSE:MCOCapital Markets

Moody’s (MCO) Valuation Check After New Pegasystems Partnership on Real-Time KYC and CLM Data Integration

Moody's (MCO) just tightened its grip on financial workflows, striking a strategic partnership with Pegasystems to feed its real time entity verification data directly into Pega’s AI driven CLM and KYC platform. See our latest analysis for Moody's. Despite the buzz around this Pegasystems deal, Moody’s share price has been treading water near $486, with a modest year to date share price gain and a far stronger three year total shareholder return suggesting longer term momentum remains intact...
NasdaqGS:RELY
NasdaqGS:RELYDiversified Financial

Remitly (RELY) Valuation Check After Investor Day Targets and ‘Rule of 40’ Profitability Push

Remitly Global (RELY) just used its Investor Day to reset the story, laying out fresh revenue targets for 2026 and 2028 while committing to a Rule of 40 balance between growth and profitability. See our latest analysis for Remitly Global. The upbeat Investor Day message seems to have sparked a short term rebound, with a 1 month share price return of 11.8 percent. However, that sits against a much weaker year to date share price return of minus 36.8 percent and a still solid three year total...
NYSE:CXW
NYSE:CXWCommercial Services

Assessing CoreCivic (CXW) Valuation After Expanded $575 Million Revolving Credit Facility Boosts Liquidity

CoreCivic (CXW) just expanded its credit firepower by amending its existing facility to lift revolving commitments by $300 million to $575 million, giving the company more room to maneuver on future projects and refinancing. See our latest analysis for CoreCivic. The move comes as CoreCivic’s share price sits at $18.78, with a solid 1 month share price return of 10.8% but a weaker year to date share price return and a negative 1 year total shareholder return, suggesting near term momentum is...
NYSE:CPA
NYSE:CPAAirlines

Assessing Copa Holdings (NYSE:CPA) Valuation After Strong Multi‑Year Share Price Gains

Copa Holdings (NYSE:CPA) has quietly rewarded patient investors, with shares up about 41% over the past year and roughly 68% over three years. This performance is prompting a fresh look at its valuation today. See our latest analysis for Copa Holdings. At around $117.47 per share, Copa’s recent pullback over the past month contrasts with its strong year to date share price return. This suggests investors are pausing to reassess growth prospects rather than abandoning the longer term total...
TSX:SCR
TSX:SCROil and Gas

Strathcona Resources (TSX:SCR) Valuation After Vawn Thermal Acquisition and Court‑Approved Special Cash Distribution

Strathcona Resources (TSX:SCR) just closed its Vawn thermal acquisition and secured court approval for a CA$10 per share special cash distribution, a one two punch that directly reshapes both its growth runway and near term shareholder returns. See our latest analysis for Strathcona Resources. Even after a small pullback, with the share price at CA$41.90 and a 30 day share price return of 3.46 percent contributing to a year to date share price return of 34.42 percent and a 1 year total...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Synopsys (SNPS) Valuation After NVIDIA’s $2 Billion Strategic Stake and Upgraded Growth Outlook

Synopsys (SNPS) just landed a multiyear strategic partnership with NVIDIA that comes with a $2 billion equity stake, instantly reframing the story around the stock and its longer term growth potential. See our latest analysis for Synopsys. The NVIDIA deal helped arrest a tough slide after lawsuits and a Q3 guidance shock. The 1 month share price return was 16.2%, even as the 1 year total shareholder return remains negative and longer term gains stay intact. If this kind of AI hardware...
NasdaqGS:AXON
NasdaqGS:AXONAerospace & Defense

Has Axon’s Recent Share Price Slip Opened a Window for Long Term Investors in 2025?

If you have been wondering whether Axon Enterprise is still worth buying after its massive run over the last few years, this breakdown is for you. The stock has slipped recently, with returns of 0.6% over the last week, -6.5% over the last month, and -8.4% year to date, but that comes after a huge 215.0% gain in three years and 355.8% over five years. Investors have been reacting to Axon's continued push into cloud based software and connected devices, alongside growing adoption of its Taser...
LSE:SRAD
LSE:SRADConsumer Durables

UK Penny Stock Insights: Diaceutics Among 3 Companies To Watch

The UK market has recently experienced a downturn, with the FTSE 100 closing lower due to weak trade data from China, highlighting the interconnectedness of global economies. Despite these challenges, investors often seek opportunities in smaller or newer companies that can offer surprising value even amid broader market volatility. Penny stocks, though an outdated term, continue to attract attention for their affordability and potential for growth when backed by strong financials.
NasdaqGS:PENG
NasdaqGS:PENGSemiconductor

Does Penguin Solutions Offer Value After Its Strong Multi Year Share Price Gains?

If you are wondering whether Penguin Solutions is quietly undervalued or just fairly priced after its latest moves, you are not alone, and that is exactly what we are going to unpack here. The stock now trades around $21.82, with returns of 1.6% over the last week, a small pullback of 2.9% over the last month, but still up 12.9% year to date and 6.1% over the past year, building on a 29.1% gain over three years and 29.5% over five years. Recent price action has been shaped by ongoing...
NasdaqGS:TW
NasdaqGS:TWCapital Markets

Is Tradeweb Markets Stock Price Justified After Expansion of Electronic Trading Footprint?

Wondering if Tradeweb Markets at around $107 is a bargain or a bubble? Let us break down what the market is really pricing in and whether that lines up with the underlying business. The stock is down about 1% over the last week, 2.3% over the past month, and roughly 18.5% year to date, but it is still up around 68.6% over three years and 65.3% over five years. Long term holders are still sitting on solid gains. Recent headlines have focused on Tradeweb expanding its electronic trading...
NasdaqGS:FCFS
NasdaqGS:FCFSConsumer Finance

What FirstCash Holdings (FCFS)'s Broad-Based Earnings Upside Means For Shareholders

Earlier this week, FirstCash Holdings reported a very strong quarter, with accelerating revenue growth and higher earnings across its U.S. and Latin American pawn businesses, complemented by an incremental boost from its newly acquired H&T pawn stores in the U.K. The company also highlighted broad-based strength at American First Finance, where lower loss provisions and improved operating margins drove substantial earnings growth in its retail point-of-sale payment solutions segment. Next,...
LSE:GLEN
LSE:GLENMetals and Mining

Is Glencore Still Attractively Priced After Its Recent Share Price Climb?

If you are wondering whether Glencore is still good value after its recent run, or if most of the upside is already priced in, you are not alone. This article is here to unpack exactly that. The stock has climbed 5.6% over the last week, 6.4% over the past month and is up 4.9% year to date, even though the 3-year return is still down 19.3% after a strong 102.5% gain over 5 years. Those moves have come as investors refocus on Glencore's role in key transition metals and reshuffle expectations...
NYSE:SPG
NYSE:SPGRetail REITs

Simon Property Group (SPG): Revisiting Valuation After a Recent Pullback in the Share Price

Simon Property Group (SPG) has quietly pulled back over the past month, even as its longer term returns remain solid. That divergence sets up an interesting moment to revisit the REIT’s fundamentals and valuation. See our latest analysis for Simon Property Group. At around $181.05 per share, Simon’s recent pullback sits against a steadier backdrop, with a positive year to date share price return and a strong multi year total shareholder return suggesting longer term momentum remains...
NYSE:BX
NYSE:BXCapital Markets

Is Blackstone (BX) Using AI And Infrastructure Deals To Reframe Its Private Credit Risk Story?

Recently, Blackstone’s CEO Stephen Schwarzman pushed back on concerns that private credit fueled recent auto-sector bankruptcies, while the firm was also reported to be in advanced talks to buy utility-parts maker MacLean Power Systems for over US$4 billion and exploring a majority stake in Indian AI infrastructure startup Neysa at a US$250–300 million valuation. Together, these developments highlight Blackstone’s effort to reassure investors about credit risk while pursuing sizeable deals...
CPSE:COLO B
CPSE:COLO BMedical Equipment

Is Coloplast’s New Board Leadership And Dividend Policy Altering The Investment Case For Coloplast (CPSE:COLO B)?

At Coloplast’s Annual General Meeting on 4 December 2025, shareholders approved a year-end dividend of DKK 18.00 per DKK 1 share, alongside significant board changes including the election of Niels B. Christiansen and the appointment of Jette Nygaard-Andersen as Chairman and Niels Peter Louis-Hansen as Deputy Chairman. These moves combine refreshed board leadership with a continued dividend payout, signaling ongoing governance renewal alongside confidence in Coloplast’s cash-generation...